Experimental Statistician’s work focused on PHC (Personalized Healthcare) aspect, but also with opportunity to work on other areas. I have conducted Meta-analysis for serotype biomarker. I have also implemented the first Comparative benefit risk (CBR) analysis within company for regulatory filing.